127 related articles for article (PubMed ID: 2972173)
1. Rapid reduction of uterine leiomyomas with monthly injections of D-Trp6-GnRH.
van Leusden HA; Dogterom AA
Gynecol Endocrinol; 1988 Mar; 2(1):45-51. PubMed ID: 2972173
[TBL] [Abstract][Full Text] [Related]
2. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
Perl V; Marquez J; Schally AV; Comaru-Schally AM; Leal G; Zacharias S; Gomez-Lira C
Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
4. Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma.
Waibel-Treber S; Minne HW; Scharla SH; Bremen T; Ziegler R; Leyendecker G
Hum Reprod; 1989 May; 4(4):384-8. PubMed ID: 2526152
[TBL] [Abstract][Full Text] [Related]
5. D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomas.
Golan A; Bukovsky I; Schneider D; Ron-el R; Herman A; Caspi E
Fertil Steril; 1989 Sep; 52(3):406-11. PubMed ID: 2528476
[TBL] [Abstract][Full Text] [Related]
6. Calcium homeostasis, bone metabolism and safety aspects during long-term treatment with a GnRH agonist.
Eckstein N; Foldes J; Feinstein Y; Vagman I; Eshel A; Steinberg R; Statter M; Limor R; Ayalon D
Maturitas; 1992 Aug; 15(1):25-32. PubMed ID: 1388219
[TBL] [Abstract][Full Text] [Related]
7. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB
Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
[TBL] [Abstract][Full Text] [Related]
8. Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH.
van Leusden HA
Lancet; 1986 Nov; 2(8517):1213. PubMed ID: 2877341
[No Abstract] [Full Text] [Related]
9. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
10. [GnRH-analogs in the therapy of uterine myomatosis].
Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
[TBL] [Abstract][Full Text] [Related]
11. Pre-surgical treatment of uterine myomas with LH-RH agonists.
D'Addato F; Repinto A; Andreoli C
Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
[TBL] [Abstract][Full Text] [Related]
12. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
Letterie GS; Coddington CC; Winkel CA; Shawker TH; Loriaux DL; Collins RL
Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132
[TBL] [Abstract][Full Text] [Related]
14. Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy.
Broekmans FJ; Hompes PG; Heitbrink MA; Netelenbos CC; Roos JC; Falke TM; Schoemaker J
Am J Obstet Gynecol; 1996 Nov; 175(5):1208-16. PubMed ID: 8942490
[TBL] [Abstract][Full Text] [Related]
15. Long-term use of an LH-RH agonist in the management of uterine leiomyomas: a study of 17 cases.
George M; Lhomme C; Lefort J; Gras C; Comaru-Schally AM; Schally AV
Int J Fertil; 1989; 34(1):19-24. PubMed ID: 2565299
[TBL] [Abstract][Full Text] [Related]
16. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study.
Maheux R; Guilloteau C; Lemay A; Bastide A; Fazekas AT
Am J Obstet Gynecol; 1985 Aug; 152(8):1034-8. PubMed ID: 3927734
[TBL] [Abstract][Full Text] [Related]
17. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri.
Coddington CC; Collins RL; Shawker TH; Anderson R; Loriaux DL; Winkel CA
Fertil Steril; 1986 May; 45(5):624-9. PubMed ID: 3084300
[TBL] [Abstract][Full Text] [Related]
18. Monthly administration of the LH-RH analogue decapeptyl for long-term treatment of ovarian dysfunctions and estrogen-dependent disorders.
Geisthoevel F; Hils K; Wieacker P; Breckwoldt M; Schultheiss H
Int J Fertil; 1989; 34(4):262-70. PubMed ID: 2570764
[TBL] [Abstract][Full Text] [Related]
19. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography.
Donnez J; Schrurs B; Gillerot S; Sandow J; Clerckx F
Fertil Steril; 1989 Jun; 51(6):947-50. PubMed ID: 2498131
[TBL] [Abstract][Full Text] [Related]
20. Use of gonadotropin-releasing hormone agonists before myomectomy.
Friedman AJ
Clin Obstet Gynecol; 1993 Sep; 36(3):650-9. PubMed ID: 8403611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
